Recombinant human TSH as an adjuvant to radioiodine for the treatment of type 1 amiodarone-induced thyrotoxicosis: a cautionary note.
Bogazzi
Fausto
F
Tomisti
Luca
L
Ceccarelli
Claudia
C
Martino
Enio
E
D000368:Aged; D000369:Aged, 80 and over; D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000139:chemically induced; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D013971:Thyrotoxicosis / Q000139:chemically induced* / Q000188:drug therapy* / Q000532:radiotherapy*; D013972:Thyrotropin / Q000009:adverse effects / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D007457:Iodine Radioisotopes; D011994:Recombinant Proteins; D013972:Thyrotropin; D000638:Amiodarone